Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease
about
(1→3)β-D-glucan testing for the detection of invasive fungal infections in immunocompromised patientsMelanized fungi in human diseaseMeta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropeniaβ-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.Molecular and nonmolecular diagnostic methods for invasive fungal infections.Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.Persistence of a positive (1,3)-beta-D-glucan test after clearance of candidemia in hematopoietic stem cell transplant recipientsA breath fungal secondary metabolite signature to diagnose invasive aspergillosisClinical utility and development of biomarkers in invasive aspergillosis.Procalcitonin as a marker of Candida species detection by blood culture and polymerase chain reaction in septic patients.Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.The application of laser microdissection in molecular detection and identification of aspergillus fumigatus from murine model of acute invasive pulmonary aspergillosis.Analysis of performance of a PCR-based assay to detect DNA of Aspergillus fumigatus in whole blood and serum: a comparative study with clinical samplesContribution of (1,3)-beta-D-glucan to diagnosis of invasive candidiasis after liver transplantation.Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections.Diagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis.The Screening Performance of Serum 1,3-Beta-D-Glucan in Patients with Invasive Fungal Diseases: A Meta-Analysis of Prospective Cohort StudiesSerum galactomannan and (1->3)-β-D-glucan assays for patients with multiple myeloma and Waldenstrom's macroglobulinemia.β-D-Glucan Screening for Detection of Invasive Fungal Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization index.Diagnosis of pneumocystis pneumonia using serum (1-3)-β-D-Glucan: a bivariate meta-analysis and systematic review.Diagnostic methods for invasive fungal diseases in patients with hematologic malignanciesInvasive fungal infections in acute leukemia.Chemotherapy-Induced Intestinal Mucosal Barrier Damage: a Cause of Falsely Elevated Serum 1,3-Beta-d-Glucan Levels?Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumoniaUltrasensitive rapid detection of human serum antibody biomarkers by biomarker-capturing viral nanofibers.Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases.Treatment of invasive candidiasis in the elderly: a review(1→3)-β-d-Glucan: A Biomarker for Microbial Translocation in Individuals with Acute or Early HIV Infection?Pneumocystis jirovecii infection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility.Antifungal prophylaxis in hematopoietic stem cell transplant recipients: the unfinished tale of imperfect success.Detection and investigation of invasive mould disease.Diagnostic methods for fungal infections in pediatric patients: microbiological, serological and molecular methods.Diagnosing invasive fungal disease in critically ill patients.ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients.Laboratory diagnostics of invasive fungal infections: an overview with emphasis on molecular approach.An Italian consensus for invasive candidiasis management (ITALIC).
P2860
Q24198039-89C6B26F-FF87-49DC-97DD-69A799E12113Q24633163-F38F539F-B790-4D3E-8FA9-C23BEA310EE0Q26778187-98574694-2432-4B5B-A666-3B983ED84D54Q26825753-98FF930D-534A-4EA4-B388-A6AA004A64DEQ31120454-CC150BDB-F580-4C5C-9FE5-1A0889924D56Q33900089-28375913-6F3C-43BB-A914-8DA89D656F36Q34057660-4DA630E0-FD5D-45BD-85A1-43E7BF364C9EQ34505582-E76C21E3-1456-41DC-B521-F9F6F8FD48AFQ34739041-63D866BF-72D0-4F72-AA7B-E5D36FE7ABA4Q35029333-FF0D652C-2EBA-470A-9763-B29E04A973D5Q35049005-6835161E-65A8-4C3A-BD75-83D8947CABCEQ35100021-4EDC4EC4-B803-48A6-B9B5-0C721733ACD7Q35193330-04A1FC7F-1FE3-4386-9001-10C0D2577C5FQ35196866-4D67B9DF-FDA4-47D4-A356-084423BC2E2BQ35273787-9901B926-49EF-43A1-BE5C-302686BAAD3BQ35331383-A0A74383-BD0D-44EE-B285-845EEF515A53Q35598171-06235B21-38C7-400D-B214-6486FA745226Q35668212-61B1B61F-8144-4F3A-90AD-5998732F440CQ35672970-A84506E5-5A59-4D6E-807E-CE23FF63E6C7Q35683091-4A422B38-19B8-43B1-905A-EEE0EC256F25Q35806943-D4A388ED-4ED5-4A8D-8184-149E7957A2F0Q35868758-8FB19A72-466A-465B-ABA9-72128C67315AQ35908296-9BFD34A1-E858-45DC-9A64-6F7FA891FE37Q36437449-950D5BED-C2EA-48E1-89D0-169096E1E7D8Q36584898-0489D63F-4B6D-4622-9D24-9C5E48B61A6BQ36612597-F46D9DE5-73BA-46C3-B4B2-5C18E22B29F7Q36620865-0E8498EC-5796-47C1-919C-86B333CD5DCEQ36744771-9BA900F4-8975-46D9-8B2D-D814A8FFA273Q37041868-6D4CCC8F-C528-4902-B262-9A8D1EBAF972Q37089475-3335205C-54CE-4177-BD9C-68FD41CBF704Q37170218-A7235A7F-78C7-4D3C-9419-A7FDE4CD6C61Q37304283-C18A06C3-B895-4F8C-8413-5182612DA1F2Q37790390-71B59B45-4DC4-497F-95AB-1917E1ABF5A4Q37806065-355557AC-243D-4E1E-AEBE-0381EE4B2EA5Q37823011-A6FCC831-8372-412E-A1EB-72701A72B24DQ37854718-B1E77A78-9C3A-42C9-AE37-57DFA3CF73D7Q37900310-AF487ACA-899D-4B52-B687-A6CCC403EAC1Q37934487-BFB4F2BC-ADD9-4C81-835F-EFAFF4AEF2A6Q38008251-99D47431-2C1F-40C7-9E7D-9617C09DEA8CQ38165883-3BD78F02-4F2E-49D6-99AE-CEF44483AEAE
P2860
Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease
description
article
@en
im Dezember 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2009
@uk
name
Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease
@en
Diagnostic Performance of the
@nl
type
label
Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease
@en
Diagnostic Performance of the
@nl
prefLabel
Diagnostic Performance of the (1→3)‐β‐d‐Glucan Assay for Invasive Fungal Disease
@en
Diagnostic Performance of the
@nl
P50
P356
P1476
Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease
@en
P2093
John H Page
Julie M Bryar
P304
P356
10.1086/647942
P407
P577
2009-12-01T00:00:00Z